Renaudin George II 4
4 · HUMANA INC · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
Humana (HUM) President George Renaudin Acquires 25 Phantom Units
What Happened
George Renaudin II, President, Insurance at Humana Inc., reported an "other acquisition" (transaction code J) on 2026-03-31 of 25 derivative units at $173.39 each, totaling $4,335. This was not an open-market stock purchase but an acquisition of phantom stock units credited under Humana’s retirement/equalization plan.
Key Details
- Transaction date: 2026-03-31; Form 4 filed: 2026-04-02 (timely).
- Security: Derivative phantom stock units; 25 units acquired at $173.39 each (total ~$4,335).
- Shares owned after transaction: Not specified in the provided filing.
- Notable footnotes:
- F5: Units are Phantom Stock Units under the Humana Retirement Equalization Plan, credited once annually and reported with code "J"; units track Humana common stock 1-for-1.
- F4: Filing also lists 9,059 restricted stock units (contingent rights to shares), exempt under Rule 16b-3.
- F2/F3: Reporting person holds stock options with multi-year vesting schedules (grants 02/24/2023 and 02/21/2024).
- Transaction type: Derivative acquisition (plan contribution), not a market purchase — often routine.
Context
Phantom stock units are bookkeeping credits that mirror share value (typically settle in cash or stock per plan) and are commonly used in retirement/equalization plans; such plan credits are routine and do not necessarily signal the insider’s market view. This report reflects a plan contribution/accrual rather than an exercise-and-sell or an open-market trade.
Insider Transaction Report
- Other
Phantom Stock Units
[F5]2026-03-31$173.39/sh+25$4,335→ 199 total(indirect: See Footnote)→ Humana Common (25 underlying)
- 16,075
Humana Common
[F4] - 542(indirect: See Footnote)
Humana Common
[F1] - 4,162
Options
[F2]Exercise: $510.24Exp: 2030-02-24→ Humana Common (4,162 underlying) - 6,966
Options
[F3]Exercise: $367.21Exp: 2031-02-21→ Humana Common (6,966 underlying)
Footnotes (5)
- [F1]Shares held for the benefit of reporting person as of February 28, 2026 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
- [F2]Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
- [F3]Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
- [F4]Includes 9,059 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
- [F5]Phantom Stock Units held for the benefit of reporting person as of February 28, 2026 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.